Dichloroacetate (DCA) enhances tumor cell death in combination with oncolytic adenovirus armed with MDA-7/IL-24

Molecular and Cellular Biochemistry

Volumn 340, Issue 1-2, 2010, Pages 31-40

  Xiao, Lianli ^a   Li, Xin ^a   Niu, Na ^a   Qian, Jing ^a   Xie, Guoliang ^a   Wang, Yigang ^a  

^a ZHEJIANG SCI TECH UNIVERSITY   (China)

Author keywords

Combination therapy; Dichloroacetate; ONYX 015; ZD55 IL 24

Indexed keywords

DICHLOROACETIC ACID; HOE 33342; INTERLEUKIN 24; INTERLEUKIN 24 PLUS ONCOLYTIC ADENOVIRUS; ONYX 015; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; INTERLEUKIN DERIVATIVE; INTERLEUKIN-24; LONTUCIREV; MESSENGER RNA; VIRUS VACCINE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BACTERIAL GENE; CANCER CELL CULTURE; CELL DEATH; CELL VIABILITY; CLINICAL EVALUATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; CYTOTOXICITY TEST; DRUG EFFICACY; DRUG POTENTIATION; DRUG SAFETY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; KIDNEY CELL CULTURE; LIVER CELL CARCINOMA; LIVER CELL CULTURE; LUNG CARCINOMA; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA; ADENOVIRIDAE; BIOSYNTHESIS; CELL SEPARATION; DOSE RESPONSE; DRUG EFFECTS; FEMALE; GENETICS; HCT116 CELL LINE; HELA CELL LINE; IMMUNOLOGY; METABOLISM; MULTIMODALITY CANCER THERAPY; NEOPLASMS; ONCOLYTIC VIROTHERAPY; PATHOLOGY; STAINING; TIME; TOXICITY; VIROLOGY; WESTERN BLOTTING;

ADENOVIRIDAE; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL SEPARATION; COMBINED MODALITY THERAPY; CYTOPATHOGENIC EFFECT, VIRAL; DICHLOROACETATE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; HCT116 CELLS; HELA CELLS; HUMANS; INTERLEUKINS; NEOPLASMS; ONCOLYTIC VIROTHERAPY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STAINING AND LABELING; TIME FACTORS; DICHLOROACETIC ACID; VIRAL VACCINES;

ADENOVIRIDAE;

EID: 77954424330     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0397-6     Document Type: Article

References (35)

1. S Bonnet SL Archer J Allalunis-Turner A Haromy C Beaulieu R Thompson, et al. 2007 A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth Cancer Cell 11 37 51 10.1016/j.ccr.2006.10.020 1:CAS:528:DC%2BD2sXhtFClsLg%3D 17222789 (Pubitemid 46054520)
2. ED Michelakis L Webster JR Mackey 2008 Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer Br J Cancer 99 989 994 10.1038/sj.bjc.6604554 1:CAS:528:DC%2BD1cXhtFyqt7vN 18766181
3. W Cao S Yacoub KT Shiverick K Namiki Y Sakai S Porvasnik, et al. 2008 Dichloroacetate (DCA) sensitizes both wild-type and over expressing Bcl-2 prostate cancer cells in vitro to radiation Prostate 68 1223 1231 10.1002/pros.20788 1:CAS:528:DC%2BD1cXhtVSktrjI 18465755
4. JY Wong GS Huggins M Debidda NC Munshi I De Vivo 2008 Dichloroacetate induces apoptosis in endometrial cancer cells Gynecol Oncol 109 394 402 10.1016/j.ygyno.2008.01.038 1:CAS:528:DC%2BD1cXmvVKrsLk%3D 18423823
5. Pan JG, Mak TW (2007) Metabolic targeting as an anticancer strategy: dawn of a new era? Sci STKE 2007: pe14
6. I Ganly D Kirn G Eckhardt GI Rodriguez DS Soutar R Otto, et al. 2000 A phase I study of Onyx-015, an E1B attenuated adenovirus, administered intratumorally to patients with recurrent head and neck cancer Clin Cancer Res 6 798 806 1:CAS:528:DC%2BD3cXisVaqt78%3D 10741699
7. D Kirn T Hermiston F McCormick 1998 ONYX-015: clinical data are encouraging Nat Med 4 1341 1342 10.1038/3902 1:STN:280:DyaK1M%2FmtV2rtw%3D%3D 9846551 (Pubitemid 28553443)
8. C Heise A Sampson-Johannes A Williams F McCormick DD Von Hoff DH Kirn 1997 ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents Nat Med 3 639 645 10.1038/nm0697-639 1:CAS:528:DyaK2sXjsFOitrk%3D 9176490 (Pubitemid 27264973)
9. FR Khuri J Nemunaitis I Ganly J Arseneau IF Tannock L Romel, et al. 2000 a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer Nat Med 6 879 885 10.1038/78638 1:CAS:528:DC%2BD3cXlsFKhtr0%3D 10932224 (Pubitemid 30644745)
10. L You CT Yang DM Jablons 2000 ONYX-015 works synergistically with chemotherapy in lung cancer cell lines and primary cultures freshly made from lung cancer patients Cancer Res 60 1009 1013 1:CAS:528:DC%2BD3cXhs1Shs7c%3D 10706117
11. XY Liu 2006 Targeting gene-virotherapy of cancer and its prosperity Cell Res 16 879 886 10.1038/sj.cr.7310108 1:CAS:528:DC%2BD28Xht1Srtb%2FN 17102812 (Pubitemid 44764197)
12. XY Liu JF Gu 2006 Targeting gene-virotherapy of cancer Cell Res 16 25 30 10.1038/sj.cr.7310005 16467873 (Pubitemid 43129306)
13. ZL Zhang WG Zou CX Luo BH Li JH Wang LY Sun, et al. 2003 An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy Cell Res 13 481 489 10.1038/sj.cr.7290191 1:CAS:528: DC%2BD2cXivVSitrw%3D 14728805 (Pubitemid 43231842)
14. M Yang X Cao MC Yu JF Gu ZH Shen M Ding, et al. 2008 Potent antitumor efficacy of ST13 for colorectal cancer mediated by oncolytic adenovirus via mitochondrial apoptotic cell death Hum Gene Ther 19 343 353 10.1089/hum.2007. 0137 1:CAS:528:DC%2BD1cXltFeitrw%3D 18355116 (Pubitemid 351591426)
15. Y Zhang J Gu L Zhao L He W Qian J Wang, et al. 2006 Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy Cancer Res 66 4291 4298 10.1158/0008-5472.CAN-05-1834 1:CAS:528:DC%2BD28XjsFSltb4%3D 16618754
16. Y Zhang X Qin Y Zhang L Zhao Y Wang X Liu, et al. 2008 Combination of ZD55-MnSOD therapy with 5-FU enhances antitumor efficacy in colorectal cancer J Cancer Res Clin Oncol 134 219 226 10.1007/s00432-007-0273-2 1:CAS:528: DC%2BD2sXhsVSls7fK 17632733 (Pubitemid 350234067)
17. CC Cunningham S Chada JA Merritt A Tong N Senzer Y Zhang, et al. 2005 Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study Mol Ther 11 149 159 10.1016/j.ymthe.2004.09.019 1:CAS:528:DC%2BD2cXhtVCls7vN 15585416 (Pubitemid 40012009)
18. R Eager L Harle J Nemunaitis 2008 Ad-MDA-7; INGN 241: a review of preclinical and clinical experience Expert Opin Biol Ther 8 1633 1643 10.1517/14712598.8.10.1633 1:CAS:528:DC%2BD1cXhtVOrtL7L 18774929
19. PB Fisher 2005 Is mda-7/IL-24 a "magic bullet" for cancer? Cancer Res 65 10128 10138 10.1158/0008-5472.CAN-05-3127 1:CAS:528: DC%2BD2MXht1WgurnM 16287994 (Pubitemid 41743698)
20. L Zhao J Gu A Dong Y Zhang L Zhong L He, et al. 2005 Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer Hum Gene Ther 16 845 858 10.1089/hum.2005.16.845 1:CAS:528:DC%2BD2MXlvVWqsL8%3D 16000066 (Pubitemid 40982333)
21. L Zhao A Dong J Gu Z Liu Y Zhang W Zhang, et al. 2006 The antitumor activity of TRAIL and IL-24 with replicating oncolytic adenovirus in colorectal cancer Cancer Gene Ther 13 1011 1022 10.1038/sj.cgt.7700969 1:CAS:528: DC%2BD28XhtVGktbrO 16799468 (Pubitemid 44564737)
22. YM Wu KJ Zhang XT Yue YQ Wang Y Yang GC Li, et al. 2009 Enhancement of tumor cell death by combining cisplatin with an oncolytic adenovirus carrying MDA-7/IL-24 Acta Pharmacol Sin 30 467 477 10.1038/aps.2009.16 1:CAS:528:DC%2BD1MXjvF2hurs%3D 19270721
23. S Zhong D Yu Y Wang S Qiu S Wu X Liu 2010 An armed oncolytic adenovirus ZD55-IL-24 combined with ADM or DDP demonstrated enhanced antitumor effect in lung cancer Acta Oncol 49 91 99 10.3109/02841860903246557 1:CAS:528: DC%2BC3cXht1Sntrk%3D 19734998
24. EA Hassoun S Ray 2003 The induction of oxidative stress and cellular death by the drinking water disinfection by-products, dichloroacetate and trichloroacetate in J774.A1 cells Comp Biochem Physiol C Toxicol Pharmacol 135 119 128 10.1016/S1532-0456(03)00082-6 12860050 (Pubitemid 36835923)
25. Q Pan B Liu J Liu R Cai Y Wang C Qian 2007 Synergistic induction of tumor cell death by combining cisplatin with an oncolytic adenovirus carrying TRAIL Mol Cell Biochem 304 315 323 10.1007/s11010-007-9514-6 1:CAS:528: DC%2BD2sXhtVKrtr3O 17577631 (Pubitemid 47456880)
26. RA Kreisberg 1980 Lactate homeostasis and lactic acidosis Ann Intern Med 92 227 237 1:CAS:528:DyaL3cXht1Khtrg%3D 6766289
27. PW Stacpoole JM Felts 1970 Diisopropylammonium dichloroacetate (DIPA) and sodium dichloracetate (DCA): effect on glucose and fat metabolism in normal and diabetic tissue Metabolism 19 71 78 10.1016/0026-0495(70)90119-8 1:CAS:528:DyaE3cXnslalsw%3D%3D 4244198
28. S Inoue M Shanker R Miyahara B Gopalan S Patel Y Oida, et al. 2006 MDA-7/IL-24-based cancer gene therapy: translation from the laboratory to the clinic Curr Gene Ther 6 73 91 10.2174/156652306775515574 1:CAS:528: DC%2BD28Xit1Sjtrs%3D 16475947
29. M Sauane ZZ Su P Gupta IV Lebedeva P Dent D Sarkar, et al. 2008 Autocrine regulation of mda-7/IL-24 mediates cancer-specific apoptosis Proc Natl Acad Sci USA 105 9763 9768 10.1073/pnas.0804089105 1:CAS:528:DC%2BD1cXovVKlsrc%3D 18599461 (Pubitemid 352031374)
30. Z Su L Emdad M Sauane IV Lebedeva D Sarkar P Gupta, et al. 2005 Unique aspects of mda-7/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7/IL-24 protein by normal cells Oncogene 24 7552 7566 10.1038/sj.onc.1208911 1:CAS:528:DC%2BD2MXht1WktrzJ 16044151 (Pubitemid 41638030)
31. M Sauane P Gupta IV Lebedeva ZZ Su D Sarkar A Randolph, et al. 2006 N-glycosylation of MDA-7/IL-24 is dispensable for tumor cell-specific apoptosis and "bystander" antitumor activity Cancer Res 66 11869 11877 10.1158/0008-5472.CAN-06-1887 1:CAS:528:DC%2BD28Xhtlagu7rI 17178884 (Pubitemid 46094199)
32. MS McMurtry S Bonnet X Wu JR Dyck A Haromy K Hashimoto, et al. 2004 Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis Circ Res 95 830 840 10.1161/01.RES.0000145360.16770.9f 1:CAS:528:DC%2BD2cXot1aitr8%3D 15375007 (Pubitemid 39390586)
33. PW Stacpoole DS Kerr C Barnes ST Bunch PR Carney EM Fennell, et al. 2006 Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children Pediatrics 117 1519 1531 10.1542/peds.2005-1226 16651305 (Pubitemid 46071378)
34. PW Stacpoole LR Gilbert RE Neiberger PR Carney E Valenstein DW Theriaque, et al. 2008 Evaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate Pediatrics 121 e1223 e1228 10.1542/peds.2007-2062 18411236
35. PW Stacpoole TL Kurtz Z Han T Langaee 2008 Role of dichloroacetate in the treatment of genetic mitochondrial diseases Adv Drug Deliv Rev 60 1478 1487 10.1016/j.addr.2008.02.014 1:CAS:528:DC%2BD1cXhtFWltbbN 18647626